Axogen, Inc. (AXGN) vs Danaher Corporation (DHR)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| AXGN | DHR | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Diagnostics & Research |
| Size band | MID | LARGE |
| Listing | Nasdaq CM | NYSE |
| Country | United States | United States |
| Theme | medical-devices | life-science-tools |
| Price and returns | ||
| Last close | $38.02 | $232.97 |
| Return · 1 week | +7.89% | +3.81% |
| Return · 1 month | −12.32% | +2.66% |
| Return · 3 months | −7.61% | +17.04% |
| Return · year to date | +22.65% | +1.33% |
| Return · 1 year | +113.96% | +5.78% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −28.14% | −4.05% |
| 52-week high | $52.91 | $242.80 |
| 52-week low | $16.79 | $160.93 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $2.23B | $163.77B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $37.43M | $834.36M |
| Employees | 622 | 58,000 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 39.18× |
| Price to earnings · forward | 52.43× | 23.64× |
| Price to sales | 8.89× | 6.15× |
| Price to book | 7.97× | 2.94× |
| Enterprise value to EBITDA | n/a (negative EBITDA) | 22.06× |
| Enterprise value to revenue | 7.78× | 7.05× |
| PEG ratio | 99.04 | 1.29 |
| Earnings per share · trailing | -0.67 | 5.61 |
| Profitability | ||
| Gross margin | 74.56% | 58.51% |
| Operating margin | −3.09% | 19.78% |
| Profit margin | −13.36% | 15.89% |
| Return on equity | −18.21% | 7.61% |
| Return on assets | −3.15% | 3.95% |
| Growth | ||
| Revenue growth | +23.10% | +5.50% |
| Earnings growth | — | +59.70% |
| Balance sheet and payout | ||
| Debt / equity (%) | 7.83 | 52.97 |
| Current ratio | 6.60 | 1.65 |
| Dividend yield | 0.00% | 0.74% |
| Payout ratio | 0.00% | 25.67% |
| Trend and volatility | ||
| RSI · 14 | 46.25 | 62.01 |
| ADX · 14 | 25.96 | 31.94 |
| 50-day average | $43.04 | $216.74 |
| 200-day average | $39.28 | $201.19 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 3.45% | 2.78% |
The full AXGN analysis
Everything this table leaves out for Axogen, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the AXGN argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full AXGN analysisThe full DHR analysis
Everything this table leaves out for Danaher Corporation: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the DHR argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full DHR analysis